Literature DB >> 17724160

First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.

James S Lewis1, Monica Herrera, Brian Wickes, Jan E Patterson, James H Jorgensen.   

Abstract

CTX-M-type extended-spectrum beta-lactamases (ESBLs) have become increasingly common worldwide, with the notable exception of the United States, where TEM- and SHV-type ESBLs have appeared to predominate. We have noted the emergence of ESBLs in our health care system (the University Health System in San Antonio, TX), especially in Escherichia coli isolates, that preferentially hydrolyze cefotaxime rather than ceftazidime, suggesting the possibility of CTX-M-type enzymes. Microbiology laboratory records were reviewed to identify ESBL-producing isolates and to compare the diameters of ceftazidime disk diffusion zones of inhibition to cefotaxime zone diameters. All isolates had been initially detected and confirmed using the procedures recommended by the Clinical and Laboratory Standards Institute. A total of 94 stored ESBL-producing isolates recovered between January 2000 and June 2006 (predominately from blood and normally sterile fluids) were retrieved for further study and screened using PCR primers specific for the presence of CTX-M, TEM, and SHV ESBLs. Only small numbers of retained ESBL-producing isolates were available for study in 2000 and 2002. The percentages of available ESBL-producing organisms in the following years were found to produce CTX-M enzymes: 2000, 25%; 2001, 10%; 2002, 0%; 2003, 60%; 2004, 69%; 2005, 89%; and 2006, 70%. The most common CTX-M-type ESBL was CTX-M-15, followed by CTX-M-16, CTX-M-8, and CTX-M-14. Comparing the disk diffusion zone diameters of cefotaxime and ceftazidime was helpful with the initial recognition of CTX-M-producing E. coli, which had an average cefotaxime zone diameter 7 mm smaller than the ceftazidime zone. However, comparing ceftazidime and cefotaxime zones for CTX-M-producing Klebsiella spp. was not helpful with initial recognition. CTX-M enzymes were also identified in Proteus mirabilis, Enterobacter spp., and Morganella morganii. Based on pulsed-field gel electrophoresis typing of the E. coli isolates, the CTX-M-producing isolates did not represent the spread of a single clone in the institution or in the community. In conclusion, CTX-M-type ESBLs are now the most common ESBL type isolated from patients in our health care system and may also be present but unrecognized in other U.S. locales.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724160      PMCID: PMC2151438          DOI: 10.1128/AAC.00576-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

2.  Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp.

Authors:  Johann D D Pitout; Ashfaque Hossain; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

3.  A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms.

Authors:  Jesus Rodriguez-Baño; David L Paterson
Journal:  Clin Infect Dis       Date:  2006-02-27       Impact factor: 9.079

4.  The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York.

Authors:  Ben M Lomaestro; Ellis H Tobin; Wenchi Shang; Thomas Gootz
Journal:  Clin Infect Dis       Date:  2006-06-19       Impact factor: 9.079

5.  Variety of TEM-, SHV-, and CTX-M-type beta-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan.

Authors:  Ling Ma; Feng-Yee Chang; Chang-Phone Fung; Te-Li Chen; Jung-Chung Lin; Po-Liang Lu; Li-Yueh Huang; Jen-Chang Chang; L K Siu
Journal:  Microb Drug Resist       Date:  2005       Impact factor: 3.431

6.  Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit.

Authors:  G Miranda; C Kelly; F Solorzano; B Leanos; R Coria; J E Patterson
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

7.  Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK.

Authors:  C J Munday; G M Whitehead; N J Todd; M Campbell; P M Hawkey
Journal:  J Antimicrob Chemother       Date:  2004-08-04       Impact factor: 5.790

8.  Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.

Authors:  David L Paterson; Wen-Chien Ko; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Robert A Bonomo; Louis B Rice; Marilyn M Wagener; Joseph G McCormack; Victor L Yu
Journal:  Clin Infect Dis       Date:  2004-06-08       Impact factor: 9.079

9.  Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals.

Authors:  M Edelstein; M Pimkin; I Palagin; I Edelstein; L Stratchounski
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

10.  Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital.

Authors:  R Ben-Ami; M J Schwaber; S Navon-Venezia; D Schwartz; M Giladi; I Chmelnitsky; A Leavitt; Y Carmeli
Journal:  Clin Infect Dis       Date:  2006-02-27       Impact factor: 9.079

View more
  72 in total

1.  Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).

Authors:  Daryl J Hoban; Samuel K Bouchillon; Stephen P Hawser; Robert E Badal; Vincent J Labombardi; Joseph DiPersio
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

2.  Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of extended-spectrum-Beta-lactamase-producing members of the enterobacteriaceae.

Authors:  Jennifer D Campbell; James S Lewis; M Leticia McElmeel; Letitia C Fulcher; James H Jorgensen
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

3.  Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.

Authors:  Reid R Hoshide; Heath Chung; Jinichi Tokeshi
Journal:  Hawaii Med J       Date:  2011-09

4.  Wild coastline birds as reservoirs of broad-spectrum-β-lactamase-producing Enterobacteriaceae in Miami Beach, Florida.

Authors:  Laurent Poirel; Anaïs Potron; Carolina De La Cuesta; Timothy Cleary; Patrice Nordmann; L Silvia Munoz-Price
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

5.  Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.

Authors:  Z A Qureshi; D L Paterson; A Y Peleg; J M Adams-Haduch; K A Shutt; D L Pakstis; E Sordillo; B Polsky; G Sandkovsky; M K Bhussar; Y Doi
Journal:  Clin Microbiol Infect       Date:  2011-09-26       Impact factor: 8.067

6.  High Diversity of CTX-M Extended-Spectrum β-Lactamases in Municipal Wastewater and Urban Wetlands.

Authors:  Timothy R Borgogna; Joanna-Lynn Borgogna; Jenna A Mielke; Celeste J Brown; Eva M Top; Ryan T Botts; David E Cummings
Journal:  Microb Drug Resist       Date:  2015-12-15       Impact factor: 3.431

7.  Rapid identification of gram-negative bacteria with and without CTX-M extended-spectrum β-lactamase from positive blood culture bottles by PCR followed by microchip gel electrophoresis.

Authors:  Shin-ichi Fujita; Kentaro Yosizaki; Thikako Ogushi; Kouhei Uechi; Yukiko Takemori; Yasuko Senda
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

8.  Recent Emergence of Escherichia coli with Cephalosporin Resistance Conferred by blaCTX-M on Washington State Dairy Farms.

Authors:  Margaret A Davis; William M Sischo; Lisa P Jones; Dale A Moore; Sara Ahmed; Diana M Short; Thomas E Besser
Journal:  Appl Environ Microbiol       Date:  2015-04-24       Impact factor: 4.792

9.  Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community.

Authors:  Nancy D Hanson; Ellen Smith Moland; S G Hong; Katie Propst; Deborah J Novak; Stephen J Cavalieri
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

10.  KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient.

Authors:  Jason W Bennett; Monica L Herrera; James S Lewis; Brian W Wickes; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.